Physician profile
Abbey Ross
NPI 1083085260
$1,686.15
in general payments reported to CMS, 2019-2025
20 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $774 · 2022: $260 · 2023: $51.11 · 2024: $162 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $443.84 | 2024-2025 | Nuzyra, Xhance |
| Smith+Nephew, INC. | $235.22 | 2022-2025 | Collagenase Santyl |
| Abbvie INC. | $215.90 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $144.42 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.89 | 2021 | |
| Amarin Pharma, INC. | $89.84 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $77.95 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.74 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $44.57 | 2021 | |
| Novo Nordisk INC | $44.33 | 2021 | |
| Lilly USA, LLC | $42.04 | 2021 | |
| Medtronic, INC. | $24.11 | 2023 | Hawkone |
| Abiomed | $20.44 | 2025 | |
| Hartmann USA, INC. | $15.84 | 2025 | Zetuvit Plus 10x10 P10 |
| E.R. Squibb & Sons, L.L.C. | $14.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $14.66 | 2025 | Adapt Ceraring, New Image |
| Merck Sharp & Dohme LLC | $13.81 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.76 | 2021 | |
| Medline Industries Lp | $13.64 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbey Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.